Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy

被引：0
|
作者：
Kohei Shitara
Keisho Chin
Takaki Yoshikawa
Hitoshi Katai
Masanori Terashima
Seiji Ito
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Toshimasa Tsujinaka
机构：
[1] National Cancer Center Hospital East,Department of Gastroenterology and Gastrointestinal Oncology
[2] Cancer Institute Hospital of JFCR,Department of Gastroenterology
[3] Kanagawa Cancer Center,Department of Gastrointestinal Surgery
[4] National Cancer Center Hospital,Gastric Surgery Division
[5] Shizuoka Cancer Center,Division of Gastric Surgery
[6] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery
[7] National Hospital Organization Osaka National Hospital,Department of Surgery
[8] Gifu University Graduate School of Medicine,Department of Surgical Oncology
[9] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[10] Hyogo College of Medicine,Department of Surgery
[11] Saiseikai Fukuoka General Hospital,Department of Surgery
[12] Kaizuka City Hospital,Department of Surgery
来源：
Gastric Cancer | 2017年 / 20卷
关键词：
Stage III gastric cancer; Adjuvant chemotherapy; Oxaliplatin; S-1; S-1 and oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：175 / 181
页数：6
相关论文
共 50 条
  • [21] Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy
    Aoyama, Toru
    Yoshikawa, Takaki
    Shirai, Junya
    Fujikawa, Hirohito
    Hayashi, Tsutomu
    Ogata, Takashi
    Cho, Haruhiko
    Yukawa, Norio
    Oshima, Takashi
    Rino, Yasushi
    Masuda, Munetaka
    Tsuburaya, Akira
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [22] Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
    Ren, Deng-Feng
    Zheng, Fang-Chao
    Zhao, Jun-Hui
    Shen, Guo-Shuang
    Ahmad, Raees
    Zhang, Shui-Sheng
    Zhang, Yu
    Kan, Jie
    Dong, Li
    Wang, Zi-Yi
    Zhao, Fu-Xing
    Zhao, Jiu-Da
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (10) : 373 - 383
  • [23] A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer
    Li, Ning
    Wu, Hui
    Xu, Xin
    Wei, Qinming
    Ding, Yongfeng
    Liu, Shan
    Wu, Jinqiong
    Zheng, Yulong
    Xu, Nong
    Gao, Yuan
    Jiang, Haiping
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
    Deng-Feng Ren
    Fang-Chao Zheng
    Jun-Hui Zhao
    Guo-Shuang Shen
    Raees Ahmad
    Shui-Sheng Zhang
    Yu Zhang
    Jie Kan
    Li Dong
    Zi-Yi Wang
    Fu-Xing Zhao
    Jiu-Da Zhao
    World Journal of Clinical Cases, 2018, (10) : 373 - 383
  • [25] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Kazumasa Fujitani
    Shigeyuki Tamura
    Yutaka Kimura
    Jin Matsuyama
    Hiroshi Imamura
    Kazuyoshi Yamamoto
    Junya Fujita
    Shohei Iijima
    Shugo Ueda
    Yukinori Kurokawa
    Toshio Shimokawa
    Taroh Satoh
    Gastric Cancer, 2020, 23 : 520 - 530
  • [26] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Matsuyama, Jin
    Imamura, Hiroshi
    Yamamoto, Kazuyoshi
    Fujita, Junya
    Iijima, Shohei
    Ueda, Shugo
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    GASTRIC CANCER, 2020, 23 (03) : 520 - 530
  • [27] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Ryohei, Kawabata
    Kazumasa, Fujitani
    Shigeyuki, Tamura
    Yutaka, Kimura
    Hiroshi, Imamura
    Junya, Fujita
    Jin, Matsuyama
    Shohei, Iijima
    Shugo, Ueda
    Yukinori, Kurokawa
    Daisuke, Sakai
    Toshio, Shimokawa
    Toshimasa, Tsujinaka
    Hiroshi, Furukawa
    Taroh, Satoh
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective study
    Jiang, Zhichao
    Sun, Yongkun
    Zhang, Wen
    Cui, Chengxu
    Yang, Lin
    Zhou, Aiping
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (03) : 180 - 186
  • [29] Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis
    Jeong, Sang-Ho
    Kim, Rock Bum
    Oh, Sung Eun
    An, Ji Yeong
    Seo, Kyung Won
    Min, Jae-Seok
    CANCERS, 2022, 14 (16)
  • [30] Outcome predictors for patients with stage II/III gastric cancer who undergo gastrectomy and S-1 adjuvant chemotherapy
    Fujiwara, Yoshinori
    Fukuda, Shuichi
    Tsujie, Masanori
    Kitani, Kotaro
    Inoue, Keisuke
    Hayashi, Tomonori
    Ishikawa, Hajime
    Yukawa, Masao
    Inoue, Masatoshi
    ONCOLOGY LETTERS, 2017, 14 (02) : 1621 - 1627
12345